India Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook

The viral vector and plasmid dna manufacturing market in India is expected to reach a projected revenue of US$ 796.3 million by 2030. A compound annual growth rate of 22.1% is expected of India viral vector and plasmid dna manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$196.4
Forecast, 2030 (US$M)
$796.3
CAGR, 2024 - 2030
22.1%
Report Coverage
India

India viral vector and plasmid dna manufacturing market, 2018-2030 (US$M)

India

Related Markets

India viral vector and plasmid dna manufacturing market highlights

  • The India viral vector and plasmid dna manufacturing market generated a revenue of USD 196.4 million in 2023 and is expected to reach USD 796.3 million by 2030.
  • The India market is expected to grow at a CAGR of 22.1% from 2024 to 2030.
  • In terms of segment, adeno-associated virus (aav) was the largest revenue generating vector type in 2023.
  • Adeno-associated virus (AAV) is the most lucrative vector type segment registering the fastest growth during the forecast period.


Viral vector and plasmid dna manufacturing market data book summary

Market revenue in 2023USD 196.4 million
Market revenue in 2030USD 796.3 million
Growth rate22.1% (CAGR from 2023 to 2030)
Largest segmentAdeno-associated virus (aav)
Fastest growing segmentAdeno-associated virus (AAV)
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAdeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids
Key market players worldwideMerck KGaA, Lonza Group Ltd, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Catalent Inc, WuXi Biologics (Cayman) Inc, Takara Bio Inc, Batavia Biosciences, Miltenyi Biotec, Revvity Inc, BioNTech SE ADR, Astellas Pharma Inc, Biomarin Pharmaceutical Inc, Regenxbio Inc


Other key industry trends

  • In terms of revenue, India accounted for 3.7% of the global viral vector and plasmid dna manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China viral vector and plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,175.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viral Vector And Plasmid DNA Manufacturing Market Companies

Name Profile # Employees HQ Website

India viral vector and plasmid dna manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.


Adeno-associated virus (aav) was the largest segment with a revenue share of 20.16% in 2023. Horizon Databook has segmented the India viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.


The Growing community awareness about cell and gene therapy promotes industrial growth. The availability of licensed gene therapy products and increase in adoption of cell & gene therapy products to treat various diseases are the key factors driving market growth in India.

Furthermore, plasmid DNA serves as the basis for gene therapies as well as DNA vaccines for a variety of infectious, hereditary & acquired disorders, as well as enteric infections.

Moreover, plasmid DNA is in demand in India due to the increase in R&D efforts for improving medicines that target a disease's genomic origin, due to the rising demand for effective disease treatment therapies.

Reasons to subscribe to India viral vector and plasmid dna manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India viral vector and plasmid dna manufacturing market databook

  • Our clientele includes a mix of viral vector and plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into India viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India viral vector and plasmid dna manufacturing market size, by vector type, 2018-2030 (US$M)

India Viral Vector And Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

India viral vector and plasmid dna manufacturing market size, by vector type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more